Korea
GC Cell Joins U.S Cancer Moonshot Project
Brining Expertise in NK Cell Therapy to Advance Efforts in Cancer Prevention, early detection, and treatment development ▶ New focus on NK cell therapy for conquering cancer ▶ GC Cell seizes the opportunity to share its cell gene therapy technology and capabilities globally ▶ Development of sol...
2023-10-25 11:27
2560
LG Energy Solution Reports Solid 3Q Operating Profit, Aims to Enhance Product Competitiveness Across All Segments
* Revenue increases 7.5 percent, operating profit up 40.1 percent year on year, primarily due to stable increase of production volume at GM JV (Ultium Cells) plant inOhio, as well as product mix improvement * The company to focus on reinforcing product competitiveness across all segments * ...
2023-10-25 09:45
2477
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO
* Lunit SCOPE IO pivotal in first phase III trial successfully showing the efficacy of immunotherapy + chemotherapy for NSCLC patients with EGFR or ALK mutation - published in theJournal of Clinical Oncology and accepted by ESMO for oral presentation SEOUL, South Korea, Oct. 24, 2023 /PRNewswir...
2023-10-24 21:00
2538
AI Diagnostic Platform Company Noul, unveils the result of Malaria study in Ethiopia and Ghana
* Reaffirming innovation as an AI-based digital microscope while presenting new malaria data at the annual meeting of the ASTMH 2023 * Noul's 'miLab™' showed significantly higher sensitivity than that of microscopy in health centers YONGIN, South Korea, Oct. 23, 2023 /PRNewswire/ -- Noul Co.,...
2023-10-23 21:00
3093
COSMAX NBT Showcases Exclusive Materials and Formulations at SSW 2023, Strengthening its Presence in the U.S. Market
* Display microemulsion technology and plant-based formulation * Various exclusive materials prepared for skin health, wrinkles, and even hair health SEONGNAM, South Korea, Oct. 23, 2023 /PRNewswire/ -- COSMAX NBT, a global leading supplements ODM (original development manufacturing) company, ...
2023-10-23 21:00
3222
VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain®
SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- VUNO Inc., South Korean
medical AI company has received 510(k) clearance from the Food and Drug
Administration (FDA) for its AI-powered brain quantification device, VUNO
Med®-DeepBrain®.
2023-10-23 21:00
3358
BACKND Expands into Global Market, Showcasing at Games on AWS 2023
* Game Backend SaaS BACKND to Showcase at 'Games on AWS 2023' * BACKND Strengthens its global presence through a robust partnership with AWS Korea. SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- AFI, the operator of BACKND, a SaaS platform for game backend, will participate in "Games on AWS...
2023-10-23 20:00
2234
SK Telecom and Deutsche Telekom to Jointly Develop Telco-specific LLM
* Companies sign LOI for joint development of a large language model specifically for telecommunication companies. * Telco-specific LLM will be built through collaboration with AI companies and unveiled in the first quarter of 2024. * Collaboration between the two companies is expected to st...
2023-10-22 13:00
3041
GC Genome to Present the Latest Lung Cancer Diagnostic Tool at ESMO 2023
- An innovative study of methylation markers and deep learning model enables precise lung cancer diagnosis. YONGIN, South Korea, Oct. 20, 2023 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present data showcasing deep learning algorithm utiliz...
2023-10-20 13:10
1935
Pocamarket's Shipping Innovation and Partnership with K-packet Enhance Member Satisfaction
* Expensive Shipping Costs? Not Anymore! Delivering Authentic K-pop Photocards from Korea SEOUL, South Korea, Oct. 19, 2023 /PRNewswire/ -- Pocamarket, the K-pop photocard trading platform, has responded to the demands of its global members by introducing a cost-effective shipping method. This ...
2023-10-19 20:00
3122
World's first expo on health and healing! 2023 Sancheong World Traditional Medicine Anti-aging Expo ends with great success
- The world's first festival on health and healing, featuring a variety of content - Opportunity to enhance the competitiveness of K-anti-aging industry and show the excellence of traditional Korean medicine to the world GYEONGNAM, South Korea, Oct. 19, 2023 /PRNewswire/ -- The 2023 Sancheong W...
2023-10-19 20:00
2140
"Craft Illuminates the Map to Humanity's Tomorrow!" The 2023 Cheongju Craft Biennale Concludes Its 45-Day Journey with 300,000 Visitors
- Going Beyond Its Role as Korea's Premier K-culture Event, Cheongju Takes a Step Closer to Realizing Its Dream of Becoming a "World Craft City" CHEONGJU, South Korea, Oct. 18, 2023 /PRNewswire/ -- Over the past 45 days, we have had the privilege of encountering crafts that connect, create, and ...
2023-10-18 21:00
2982
CJ Foods Partners with T&R Biofab to Shape the Future of Food
CJ Foods and T&R Biofab aim to synergize their unique expertise and technologies to bring to the market innovative food products SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- CJ Foods, a business unit of South Korea-based CJ CheilJedang, announced that it entered into a joint development agre...
2023-10-18 21:00
3047
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
* With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceutical industry * Appoints Chief Commercial Officer Andrew Fenny to strengthen its global marketing capabilities * Shortlisted as a finalist for ...
2023-10-18 20:00
2195
ZEPETO Partners with Fuji TV to Launch a Joint Virtual Avatar Audition Program
SEONGNAM, South Korea, Oct. 17, 2023 /PRNewswire/ -- ZEPETO announced it has forged a strategic partnership with Fuji Television Network, one of the largest television networks inJapan. As a first step, they've unveiled their first joint program, the "Shar-Pule" Avatar Audition Program initiative...
2023-10-17 21:00
3520
Global Healthcare Startup Sky Labs Attracts Investments Totaling KRW 20.7 Billion in a Series C Round
- Major investors include Korea Development Bank (KDB), K2 Investment Partners, DEVSISTERS VENTURES, SJG Partners, and OPENWATER INVESTMENT - Distribution of 'CART BP,' a ring-type cuffless blood pressure monitor that enables continuous blood pressure measurement and monitoring 24/7, will be ful...
2023-10-17 20:00
2370
New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023
- Nine abstracts, featuring the effectiveness of Lunit's AI-powered TIL/WSI analyzer and biomarker platform, accepted by the ESMO 2023 Congress SEOUL, South Korea, Oct. 16, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeut...
2023-10-16 21:10
2550
POSCO Group Devotes Its Full Resources to Support Busan's Bid for World Expo 2030
* With the commitment to serve as ambassadors supporting Busan's bid for World Expo 2030, all POSCO Group employees actively contribute to the group's daily efforts to attract this global event. * Chairman Jeong-woo Choi of POSCO Group reached out to global society for support, and the group'...
2023-10-16 20:00
2690
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
New data presented on novel orally bioavailable p300-selective degraders showing significant anti-tumor activity in preclinical models of androgen receptor (AR) positive prostate cancer SEOUL, South Korea and KING OF PRUSSIA, Pa., Oct. 12, 2023 /PRNewswire/ -- SK Biopharmaceuticals, a global bio...
2023-10-13 09:00
2947
Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy
.. First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progression free survival by ~30 months compared to chemotherapy alone1 .. Phase 3 results expected in 2025 .. Exclusive license for AU, NZ, Singapore, Mal...
2023-10-13 03:00
3439
Week's Top Stories
Most Reposted
TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia
[Picked up by 316 media titles]
2026-06-08 10:16
DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 303 media titles]
2026-06-04 23:55
Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 296 media titles]
2026-06-05 19:08
DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 294 media titles]
2026-06-05 15:00Omni HR Launches Mino, the First AI Agent Built on Unified APAC HR Data
[Picked up by 283 media titles]
2026-06-08 09:00
Most Read
YY Group (NASDAQ: YYGH) Wins Prestigious HAPA Solutions Excellence Award, Validating Enterprise AI Marketplace Adoption in Southeast Asia
2026-06-05 19:37
8727
Dreame ranked No.1 in Global Robot Vacuum Sales & Revenue, according to International Data Corporation (IDC)
2026-06-05 21:05
8123
Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
2026-06-05 22:00
7633
Tuniu Announces Unaudited First Quarter 2026 Financial Results
2026-06-05 18:00
7564
